These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 18716952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of pediatric vogt-koyanagi-harada syndrome with infliximab.
    Khalifa YM, Bailony MR, Acharya NR.
    Ocul Immunol Inflamm; 2010 Jun; 18(3):218-22. PubMed ID: 20482402
    [Abstract] [Full Text] [Related]

  • 3. Successful use of infliximab therapy in sight-threatening corticosteroid-resistant Vogt-Koyanagi-Harada disease.
    Zmuda M, Tiev KP, Knoeri J, Héron E.
    Ocul Immunol Inflamm; 2013 Aug; 21(4):310-6. PubMed ID: 23617262
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
    Khalifa Y, Loh AR, Acharya NR.
    Ocul Immunol Inflamm; 2009 Aug; 17(6):431-3. PubMed ID: 20001265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, Lehoang P, Lemaitre C, Okada AA, Pivetti-Pezzi P, Secchi A, See RF, Tabbara KF, Usui M, Rao NA.
    Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Lee GE, Lee BW, Rao NA, Fawzi AA.
    Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Choroidal folds in acute Vogt-Koyanagi-Harada disease.
    Zhao C, Zhang M, Wen X, Dong F, Han B, Du H.
    Ocul Immunol Inflamm; 2009 Feb; 17(4):282-8. PubMed ID: 19657984
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    Zhang M, Liu Q, Min H, Du H, Hu T.
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    Tsujikawa A, Yamashiro K, Yamamoto K, Nonaka A, Fujihara M, Kurimoto Y.
    Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
    [Abstract] [Full Text] [Related]

  • 18. [Vogt-Koyanagi-Harada syndrome. Epidemiological, clinical and disease progression aspects. Twenty cases].
    Boutimzine N, Laghmari A, Ouazzani I, Ibrahimy W, Mohcine Z.
    J Fr Ophtalmol; 1998 Dec; 21(10):746-54. PubMed ID: 10052048
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.